PMEF
TNDM icon

Point72 Middle East FZE’s Tandem Diabetes Care TNDM Stock Holding History

Point72 Middle East FZE’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,348
Closed -$236K – 1880
2023
Q3 		$236K Sell
11,348
-956
-8% -$26.3K 0.01% 989
2023
Q2 		$302K Buy
+12,304
New +$396K 0.01% 930
2023
Q1 		– Sell
-10,225
Closed -$460K – 2203
2022
Q4 		$460K Buy
+10,225
New +$463K 0.02% 762

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Middle East FZE's TNDM Position: Q4 2023 in Review

Point72 Middle East FZE sold out of Tandem Diabetes Care (TNDM) in Q4 2023, closing a stake of 11,348 shares — an estimated $236K sold.

Point72 Middle East FZE first reported a position in TNDM in Q4 2022 and held it in 3 quarters. The position peaked at $460K in Q4 2022. 268 funds tracked by Wall St. Rank hold TNDM as of Q4 2023.

  • Point72 Middle East FZE reported no remaining Tandem Diabetes Care position as of Q4 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 11,348 Tandem Diabetes Care shares in Q4 2023, an estimated $236K.
  • Point72 Middle East FZE first reported a position in Tandem Diabetes Care in Q4 2022 and held it in 3 quarters.
  • Point72 Middle East FZE's Tandem Diabetes Care position peaked at $460K in Q4 2022.
  • 268 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.